"Dexmedetomidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A imidazole derivative that is an agonist of ADRENERGIC ALPHA-2 RECEPTORS. It is closely-related to MEDETOMIDINE, which is the racemic form of this compound.
| Descriptor ID |
D020927
|
| MeSH Number(s) |
D03.383.129.308.245
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dexmedetomidine".
Below are MeSH descriptors whose meaning is more specific than "Dexmedetomidine".
This graph shows the total number of publications written about "Dexmedetomidine" by people in this website by year, and whether "Dexmedetomidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 1 | 3 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dexmedetomidine" by people in Profiles.
-
Minimal Sedation Use for Laceration Repair in the Pediatric Emergency Department. J Emerg Med. 2025 08; 75:1-13.
-
Sinus Arrest Related to Dexmedetomidine Infusion in an Infant; a Case Report and Review of Current Literature. J Pharm Pract. 2024 Aug; 37(4):1026-1031.
-
Retrospective Comparison of Intranasal Dexmedetomidine and Oral Chloral Hydrate for Sedated Auditory Brainstem Response Exams. Hosp Pediatr. 2016 Mar; 6(3):166-71.
-
The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001 Nov; 93(5):1205-9.